Filters
reset allOther countries
Results: 1 to 19 of 19
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
Centogene AG - the Rare Disease Company Germany | 417 | 413 |
|
Invitae United States | 57 | 27 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Anterior Segment Dysgenesis Disorders Panel PreventionGenetics United States | 272 | 278 |
|
PreventionGenetics United States | 157 | 171 |
|
PreventionGenetics United States | 40 | 27 |
|
Congenital Cataracts and Ayme-Gripp Syndrome via the MAF Gene PreventionGenetics United States | 2 | 1 |
|
PreventionGenetics United States | 38 | 24 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 2 | 1 |
|
Cataract panel. NGS panel of 69 genes. Genologica Medica Spain | 146 | 69 |
|
Corneal dystrophy panel. NGS panel of 27 genes. Genologica Medica Spain | 44 | 27 |
|
Glaucoma panel. 18-gene NGS panel. Genologica Medica Spain | 44 | 18 |
|
Ayme-Gripp syndrome: Full gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 1 |
|
Optic Atrophy & Early Glaucoma NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 40 | 34 |
|
Invitae United States | 46 | 32 |
|
Results: 1 to 19 of 19
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.